but first let's shift our attention over |
4.56 |
Jump to 4.4 |
|
|
children under five a big development |
2.881 |
Jump to 13.599 |
|
|
two and three doses in our younger age |
4.32 |
Jump to 70.56 |
|
|
rather that the a two dose vaccine was |
5.2 |
Jump to 77.2 |
|
|
not as effective for that under five |
4.239 |
Jump to 79.92 |
|
|
group and so they're looking at a third |
4.399 |
Jump to 82.4 |
|
|
either way if they do need three doses |
4.48 |
Jump to 87.52 |
|
|
the process of the two doses for the |
4.879 |
Jump to 98.24 |
|
|
the last two years we've become |
3.28 |
Jump to 112.24 |
|
|
visor being the only one that is at this |
4.32 |
Jump to 159.68 |
|
|
that 5 to 11 cohort of of a patient |
6.321 |
Jump to 166.239 |
|
|
stagnant about 20 percent of the |
4.959 |
Jump to 177.2 |
|
|
five to eleven so that shows that there |
4.8 |
Jump to 182.159 |
|
|
your point yes there are five and under |
3.841 |
Jump to 186.959 |
|
|